San Francisco Sentry Investment Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $142K | Sell |
2,852
-56
| -2% | -$2.79K | 0.07% | 238 |
|
|
2021
Q1 | $130K | Buy |
2,908
+876
| +43% | +$39.2K | 0.06% | 270 |
|
|
2020
Q4 | $93K | Buy |
2,032
+1,512
| +291% | +$69.2K | 0.04% | 283 |
|
|
2020
Q3 | $24K | Sell |
520
-600
| -54% | -$27.7K | 0.01% | 408 |
|
|
2020
Q2 | $57K | Hold |
1,120
| – | – | 0.03% | 310 |
|
|
2020
Q1 | $53K | Buy |
1,120
+600
| +115% | +$28.4K | 0.03% | 277 |
|
|
2019
Q4 | $31K | Hold |
520
| – | – | 0.01% | 423 |
|
|
2019
Q3 | $28K | Hold |
520
| – | – | 0.01% | 434 |
|
|
2019
Q2 | $26K | Hold |
520
| – | – | 0.01% | 443 |
|
|
2019
Q1 | $27K | Hold |
520
| – | – | 0.01% | 453 |
|
|
2018
Q4 | $25K | Sell |
520
-4,231
| -89% | -$203K | 0.01% | 436 |
|
|
2018
Q3 | $238K | Sell |
4,751
-8
| -0.2% | -$401 | 0.09% | 173 |
|
|
2018
Q2 | $240K | Buy |
4,759
+348
| +8% | +$17.6K | 0.1% | 177 |
|
|
2018
Q1 | $216K | Buy |
4,411
+20
| +0.5% | +$979 | 0.06% | 260 |
|
|
2017
Q4 | $194K | Sell |
4,391
-2,608
| -37% | -$115K | 0.06% | 266 |
|
|
2017
Q3 | $356K | Buy |
6,999
+3,671
| +110% | +$187K | 0.12% | 171 |
|
|
2017
Q2 | $179K | Sell |
3,328
-1,024
| -24% | -$55.1K | 0.06% | 239 |
|
|
2017
Q1 | $229K | Buy |
4,352
+4
| +0.1% | +$210 | 0.13% | 170 |
|
|
2016
Q4 | $210K | Buy |
+4,348
| New | +$210K | 0.12% | 171 |
|
|
2014
Q4 | – | Sell |
-784
| Closed | -$45K | – | 256 |
|
|
2014
Q3 | $45K | Hold |
784
| – | – | 0.02% | 309 |
|
|
2014
Q2 | $52K | Sell |
784
-12
| -2% | -$796 | 0.02% | 313 |
|
|
2014
Q1 | $53K | Buy |
796
+32
| +4% | +$2.13K | 0.02% | 353 |
|
|
2013
Q4 | $51K | Buy |
764
+92
| +14% | +$6.14K | 0.02% | 323 |
|
|
2013
Q3 | $42K | Buy |
672
+120
| +22% | +$7.5K | 0.02% | 328 |
|
|
2013
Q2 | $34K | Buy |
+552
| New | +$34K | 0.01% | 347 |
|